umarjan11/Medical-qna huggingface dataset:
Question: How many people are affected by adenylosuccinate lyase deficiency ?

Answer: Adenylosuccinate lyase deficiency is a rare disorder; fewer than 100 cases have been reported. The condition is most common in the Netherlands and Belgium, but it has been found worldwide.
Question: How many people are affected by phosphoribosylpyrophosphate synthetase superactivity ?

Answer: PRS superactivity is believed to be a rare disorder. Approximately 30 families with the condition have been reported. More than two thirds of these families are affected by the milder form of the disease.
Question: How many people are affected by cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy ?

Answer: CARASIL appears to be a rare condition. It has been identified in about 50 people, primarily in Japan and China.
Question: How many people are affected by leukoencephalopathy with vanishing white matter ?

Answer: The prevalence of leukoencephalopathy with vanishing white matter is unknown. Although it is a rare disorder, it is believed to be one of the most common inherited diseases that affect the white matter.
Question: How many people are affected by Werner syndrome ?

Answer: Werner syndrome is estimated to affect 1 in 200,000 individuals in the United States. This syndrome occurs more often in Japan, affecting 1 in 20,000 to 1 in 40,000 people.
Question: How many people are affected by acral peeling skin syndrome ?

Answer: Acral peeling skin syndrome is a rare condition, with several dozen cases reported in the medical literature. However, because its signs and symptoms tend to be mild and similar to those of other skin disorders, the condition is likely underdiagnosed.
Question: How many people are affected by intestinal pseudo-obstruction ?

Answer: Primary intestinal pseudo-obstruction is a rare disorder. Its prevalence is unknown. The prevalence of secondary intestinal pseudo-obstruction is also unknown, but it is believed to be more common than the primary form.
Question: What is (are) Prevent diabetes problems: Keep your kidneys healthy ?

Answer: Kidney failure, also called end-stage kidney disease or ESRD, means your kidneys no longer work well enough to do their job. You will need treatment to replace the work your kidneys have stopped doing.
Question: What is (are) Gout ?

Answer: The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) at NIH has more information about gout. Check out the information  here. Also, see  "Key Words"  related to gout.
Question: What is the outlook for Multiple System Atrophy with Orthostatic Hypotension ?

Answer: Most individuals with multiple system atrophy with orthostatic hypotension die within 7 to 10 years after the onset of symptoms. A problem with the respiratory system is the most common cause of death.
Question: what research (or clinical trials) is being done for Paroxysmal Choreoathetosis ?

Answer: NINDS supports and conducts research on movement disorders such as paroxysmal choreoathetosis. Much of this research is aimed at finding ways to prevent and treat these disorders.
Question: What is the outlook for Whiplash ?

Answer: Generally, prognosis for individuals with whiplash is good. The neck and head pain clears within a few days or weeks. Most patients recover within 3 months after the injury, however, some may continue to have residual neck pain and headaches.
Question: what research (or clinical trials) is being done for Striatonigral Degeneration ?

Answer: The NINDS supports and conducts research on disorders of the brain and nervous system such as striatonigral degeneration. This research focuses on finding ways to prevent and treat these disorders.
Question: What is the outlook for Parry-Romberg ?

Answer: The prognosis for individuals with Parry-Romberg syndrome varies. In some cases, the atrophy ends before the entire face is affected. In mild cases, the disorder usually causes no disability other than cosmetic effects.
Question: What is the outlook for Gerstmann's Syndrome ?

Answer: In adults, many of the symptoms diminish over time. Although it has been suggested that in children symptoms may diminish over time, it appears likely that most children probably do not overcome their deficits, but learn to adjust to them.
Question: What is the outlook for Mitochondrial Myopathy ?

Answer: The prognosis for patients with mitochondrial myopathies varies greatly, depending largely on the type of disease and the degree of involvement of various organs. These disorders cause progressive weakness and can lead to death.
Question: How many people are affected by xeroderma pigmentosum ?

Answer: Xeroderma pigmentosum is a rare disorder; it is estimated to affect about 1 in 1 million people in the United States and Europe. The condition is more common in Japan, North Africa, and the Middle East.
Question: How many people are affected by hereditary cerebral amyloid angiopathy ?

Answer: The prevalence of hereditary cerebral amyloid angiopathy is unknown. The Dutch type is the most common, with over 200 affected individuals reported in the scientific literature.
Question: How many people are affected by Kallmann syndrome ?

Answer: Kallmann syndrome is estimated to affect 1 in 10,000 to 86,000 people and occurs more often in males than in females. Kallmann syndrome 1 is the most common form of the disorder.
Question: How many people are affected by myotonia congenita ?

Answer: Myotonia congenita is estimated to affect 1 in 100,000 people worldwide. This condition is more common in northern Scandinavia, where it occurs in approximately 1 in 10,000 people.
Question: Is androgenetic alopecia inherited ?

Answer: The inheritance pattern of androgenetic alopecia is unclear because many genetic and environmental factors are likely to be involved. This condition tends to cluster in families, however, and having a close relative with patterned hair loss appears to be a risk factor for developing the condition.
Question: How many people are affected by Sheldon-Hall syndrome ?

Answer: The prevalence of Sheldon-Hall syndrome is unknown; however, it is thought to be the most common type of distal arthrogryposis. About 100 affected individuals have been described in the medical literature.
Question: How many people are affected by prion disease ?

Answer: These disorders are very rare. Although the exact prevalence of prion disease is unknown, studies suggest that this group of conditions affects about one person per million worldwide each year. Approximately 350 new cases are reported annually in the United States.
Question: How many people are affected by aromatic l-amino acid decarboxylase deficiency ?

Answer: AADC deficiency is a rare disorder. Only about 100 people with this condition have been described in the medical literature worldwide; about 20 percent of these individuals are from Taiwan.
Question: Is paroxysmal nocturnal hemoglobinuria inherited ?

Answer: This condition is acquired, rather than inherited. It results from new mutations in the PIGA gene, and generally occurs in people with no previous history of the disorder in their family. The condition is not passed down to children of affected individuals.
Question: How many people are affected by optic atrophy type 1 ?

Answer: Optic atrophy type 1 is estimated to affect 1 in 50,000 people worldwide. This condition is more common in Denmark, where it affects approximately 1 in 10,000 people.
Question: How many people are affected by pseudocholinesterase deficiency ?

Answer: Pseudocholinesterase deficiency occurs in 1 in 3,200 to 1 in 5,000 people. It is more common in certain populations, such as the Persian Jewish community and Alaska Natives.
Question: How many people are affected by X-linked infantile nystagmus ?

Answer: The incidence of all forms of infantile nystagmus is estimated to be 1 in 5,000 newborns; however, the precise incidence of X-linked infantile nystagmus is unknown.
Question: Is rheumatoid arthritis inherited ?

Answer: The inheritance pattern of rheumatoid arthritis is unclear because many genetic and environmental factors appear to be involved. However, having a close relative with rheumatoid arthritis likely increases a person's risk of developing the condition.
Question: How many people are affected by globozoospermia ?

Answer: Globozoospermia is a rare condition that is estimated to affect 1 in 65,000 men. It is most common in North Africa, where it accounts for approximately 1 in 100 cases of male infertility.
Question: How many people are affected by 3-hydroxyacyl-CoA dehydrogenase deficiency ?

Answer: The exact incidence of 3-hydroxyacyl-CoA dehydrogenase deficiency is unknown; it has been reported in only a small number of people worldwide.
Question: How many people are affected by benign essential blepharospasm ?

Answer: Benign essential blepharospasm affects an estimated 20,000 to 50,000 people in the United States. For unknown reasons, it occurs in women more than twice as often as it occurs in men.
Question: What is (are) Short Bowel Syndrome ?

Answer: The large intestine is about 5 feet long in adults and absorbs water and any remaining nutrients from partially digested food passed from the small intestine. The large intestine then changes waste from liquid to a solid matter called stool.
Question: What causes Medullary Sponge Kidney ?

Answer: Scientists do not fully understand the cause of medullary sponge kidney or why cysts form in the tubules during fetal development. Even though medullary sponge kidney is present at birth, most cases do not appear to be inherited.
Question: What are the symptoms of Heart Attack ?

Answer: No. Most heart attack patients do not have all of the symptoms. The important thing to remember is that if you have any of the symptoms and they grow more intense, and last more than 5 minutes, you should call 9-1-1 immediately.
Question: What is (are) Fowler's syndrome ?

Answer: Fowlers syndrome is characterized by urinary retention associated with abnormal electromyographic activity in young women in the absence of overt neurologic disease. Some women with this syndrome have polycystic ovaries as well.
Question: What causes Erdheim-Chester disease ?

Answer: What causes Erdheim-Chester disease? The specific underlying cause of Erdheim-Chester disease is not known. It is not currently categorized as a cancer, infection or autoimmune disease. It it not believed to be contagious or genetic in nature.
Question: How to diagnose Phacomatosis pigmentovascularis ?

Answer: How might phacomatosis pigmentovascularis be diagnosed? Diagnosis of phacomatosis pigmentovascularis is based primarily on physical evaluation and appearence of the skin lesions.
Question: What are the treatments for Parasites - Paragonimiasis (also known as Paragonimus Infection) ?

Answer: Paragonimus infections are treatable by your health care provider. Prescription medications are available.
    
More on: Resources for Health Professionals: Treatment
Question: what research (or clinical trials) is being done for Neuroleptic Malignant Syndrome ?

Answer: The NINDS supports research on neurological disorders such as neuroleptic malignant syndrome. Much of this research focuses on finding ways to prevent and treat the disorder.
Question: what research (or clinical trials) is being done for Spasticity ?

Answer: The NINDS supports research on brain and spinal cord disorders that can cause spasticity. The goals of this research are to increase scientific understanding about these disorders and to find ways to prevent, treat, and cure them.
Question: What is the outlook for Meralgia Paresthetica ?

Answer: Meralgia paresthetica usually has a good prognosis. In most cases, meralgia paresthetica will improve with conservative treatment or may even spontaneously resolve. Surgical intervention is not always fully successful.
Question: What is the outlook for Huntington's Disease ?

Answer: Huntingtons disease causes disability that gets worse over time. People with this disease usually die within 15 to 20 years following diagnosis. At this time, no treatment is available to slow, stop or reverse the course of HD.
Question: What is the outlook for Aicardi Syndrome ?

Answer: The prognosis for girls with Aicardi syndrome varies according to the severity of their symptoms. There is an increased risk for death in childhood and adolescence, but survivors into adulthood have been described.
Question: What is the outlook for Familial Periodic Paralyses ?

Answer: The prognosis for the familial periodic paralyses varies. Chronic attacks may result in progressive weakness that persists between attacks. Some cases respond well to treatment, which can prevent or reverse progressive muscle weakness.
Question: How many people are affected by glycogen storage disease type IV ?

Answer: GSD IV is estimated to occur in 1 in 600,000 to 800,000 individuals worldwide. Type IV accounts for roughly 3 percent of all cases of glycogen storage disease.
Question: How many people are affected by Beckwith-Wiedemann syndrome ?

Answer: Beckwith-Wiedemann syndrome affects an estimated 1 in 13,700 newborns worldwide. The condition may actually be more common than this estimate because some people with mild symptoms are never diagnosed.
Question: How many people are affected by peroxisomal acyl-CoA oxidase deficiency ?

Answer: Peroxisomal acyl-CoA oxidase deficiency is a rare disorder. Its prevalence is unknown. Only a few dozen cases have been described in the medical literature.
Question: Is familial encephalopathy with neuroserpin inclusion bodies inherited ?

Answer: FENIB is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder. In many cases, an affected person has a parent with the condition.
Question: How many people are affected by pyridoxine-dependent epilepsy ?

Answer: Pyridoxine-dependent epilepsy occurs in 1 in 100,000 to 700,000 individuals. At least 100 cases have been reported worldwide.
Question: How many people are affected by Naegeli-Franceschetti-Jadassohn syndrome/dermatopathia pigmentosa reticularis ?

Answer: NFJS/DPR is a rare condition; its prevalence is unknown. Only a few affected families have been reported in the medical literature.
Question: How many people are affected by spinocerebellar ataxia type 36 ?

Answer: Approximately 100 individuals with SCA36 have been reported in the scientific literature. Almost all of these individuals have been from two regions: western Japan and the Costa de Morte in Galicia, Spain.
Question: How many people are affected by congenital hyperinsulinism ?

Answer: Congenital hyperinsulinism affects approximately 1 in 50,000 newborns. This condition is more common in certain populations, affecting up to 1 in 2,500 newborns.
Question: How many people are affected by lamellar ichthyosis ?

Answer: Lamellar ichthyosis is estimated to affect 1 in 100,000 individuals in the United States. This condition is more common in Norway, where an estimated 1 in 91,000 individuals are affected.
Question: How many people are affected by type A insulin resistance syndrome ?

Answer: Type A insulin resistance syndrome is estimated to affect about 1 in 100,000 people worldwide. Because females have more health problems associated with the condition, it is diagnosed more often in females than in males.
Question: How many people are affected by Heart Attack ?

Answer: Very common. Each year, more than 1 million people in the U.S. have a heart attack and about half of them die. About one-half of those who die do so within 1 hour of the start of symptoms and before reaching the hospital.
Question: What are the treatments for Jejunal atresia ?

Answer: How might jejunal atresia be treated? Jejunal atresia is typically treated with surgery. Total parenteral nutrition (TPN) is generally necessary for a period of time following surgery until normal meals are tolerated.
Question: Is Glass-Chapman-Hockley syndrome inherited ?

Answer: How is Glass-Chapman-Hockley syndrome inherited? Based on the only family that has been reported in the medical literature, to date, the syndrome is believed to be inherited in an autosomal dominant manner.
Question: What are the treatments for Kyasanur Forest Disease (KFD) ?

Answer: There is no specific treatment for KFD, but early hospitalization and supportive therapy is important. Supportive therapy includes the maintenance of hydration and the usual precautions for patients with bleeding disorders.
Question: What is the outlook for Multiple System Atrophy ?

Answer: The disease tends to advance rapidly over the course of 5 to 10 years, with progressive loss of motor skills, eventual confinement to bed, and death. There is no remission from the disease. There is currently no cure.
Question: What are the treatments for Prosopagnosia ?

Answer: The focus of any treatment should be to help the individual with prosopagnosia develop compensatory strategies. Adults who have the condition as a result of stroke or brain trauma can be retrained to use other clues to identify individuals.
Question: What is the outlook for Paroxysmal Hemicrania ?

Answer: Many patients experience complete to near-complete relief of symptoms following physician-supervised medical treatment. Paroxysmal hemicrania may last indefinitely but has been known to go into remission or stop spontaneously.
Question: How many people are affected by hereditary angiopathy with nephropathy, aneurysms, and muscle cramps syndrome ?

Answer: HANAC syndrome is a rare condition, although the exact prevalence is unknown. At least six affected families have been described in the scientific literature.
Question: Is hereditary diffuse gastric cancer inherited ?

Answer: HDGC is inherited in an autosomal dominant pattern, which means one copy of the altered CDH1 gene in each cell is sufficient to increase the risk of developing cancer.  In most cases, an affected person has one parent with the condition.
Question: How many people are affected by primary sclerosing cholangitis ?

Answer: An estimated 1 in 10,000 people have primary sclerosing cholangitis, and the condition is diagnosed in approximately 1 in 100,000 people per year worldwide.
Question: Is primary sclerosing cholangitis inherited ?

Answer: The inheritance pattern of primary sclerosing cholangitis is unknown because many genetic and environmental factors are likely to be involved. This condition tends to cluster in families, however, and having an affected family member is a risk factor for developing the disease.
Question: How many people are affected by rapid-onset dystonia parkinsonism ?

Answer: Rapid-onset dystonia parkinsonism appears to be a rare disorder, although its prevalence is unknown. It has been diagnosed in individuals and families from the United States, Europe, and Korea.
Question: How many people are affected by short stature, hyperextensibility, hernia, ocular depression, Rieger anomaly, and teething delay ?

Answer: SHORT syndrome is a rare condition; its prevalence is unknown. Only a few affected individuals and families have been reported worldwide.
Question: How many people are affected by Timothy syndrome ?

Answer: Timothy syndrome is a rare condition; fewer than 20 people with this disorder have been reported worldwide. The classic type of Timothy syndrome appears to be more common than the atypical type, which has been identified in only two individuals.
Question: How many people are affected by task-specific focal dystonia ?

Answer: Task-specific focal dystonia affects an estimated 7 to 69 per million people in the general population. Musician's dystonia that is severe enough to impact performance occurs in about 1 percent of musicians.
Question: How many people are affected by lattice corneal dystrophy type II ?

Answer: Lattice corneal dystrophy type II is a rare condition; however, the prevalence is unknown. While this condition can be found in populations worldwide, it was first described in Finland and is more common there.
Question: Is GRN-related frontotemporal dementia inherited ?

Answer: This condition is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder. In most cases, an affected person has a parent and other family members with the condition.
Question: How many people are affected by surfactant dysfunction ?

Answer: One type of surfactant dysfunction, SP-B deficiency, is estimated to occur in 1 in 1 million newborns worldwide. The prevalence of surfactant dysfunction due to other causes is unknown.
Question: How many people are affected by Sjgren-Larsson syndrome ?

Answer: Sjgren-Larsson syndrome was first observed in Sweden, where the prevalence of this condition is 1 per 250,000 individuals. Outside Sweden, the prevalence of this condition is unknown.
Question: How many people are affected by 3-methylglutaconyl-CoA hydratase deficiency ?

Answer: 3-methylglutaconyl-CoA hydratase deficiency is a rare disorder; at least 20 cases have been reported in the scientific literature.
Question: How to prevent Alagille Syndrome ?

Answer: Scientists have not yet found a way to prevent Alagille syndrome. However, complications of the disorder can be managed with the help of health care providers. Routine visits with a health care team are needed to prevent complications from becoming worse.
Question: How many people are affected by Hemorrhoids ?

Answer: About 75 percent of people will have hemorrhoids at some point in their lives.1 Hemorrhoids are most common among adults ages 45 to 65.2 Hemorrhoids are also common in pregnant women.
Question: Who is at risk for Biliary Atresia? ?

Answer: Biliary atresia is rare and only affects about one out of every 18,000 infants.1 The disease is more common in females, premature babies, and children of Asian or African American heritage.
Question: What is (are) Diabetic Retinopathy ?

Answer: In this test, a special dye is injected into your arm. Pictures are taken as the dye passes through the blood vessels in your retina. The test allows your eye care professional to identify any leaking blood vessels and recommend treatment.
Question: What is (are) Stroke ?

Answer: For more information on stroke, including research sponsored by the National Institute of Neurological Disorders and Stroke, call 1-800-352-9424 or visit the Web site at www.ninds.nih.gov.
Question: What is (are) Divorce ?

Answer: Divorce is the legal breakup of a marriage. Like every major life change, divorce is stressful. It affects finances, living arrangements, household jobs, schedules, and more. If the family includes children, they may be deeply affected.
Question: What are the treatments for Reticulohistiocytoma ?

Answer: How might reticulohistiocytoma be treated? Reticulohistiocytoma (RH) typically resolve spontaneously over a period of months to years; however, surgical excision usually results in a cure.
Question: what research (or clinical trials) is being done for Locked-In Syndrome ?

Answer: The NINDS supports research on neurological disorders that can cause locked-in syndrome. The goals of this research are to find ways to prevent, treat, and cure these disorders.
Question: What is the outlook for Paroxysmal Choreoathetosis ?

Answer: Generally, paroxysmal choreoathetosis lessens with age, and many adults have a complete remission. Because drug therapy is so effective, the prognosis for the disorder is good.
Question: what research (or clinical trials) is being done for Whiplash ?

Answer: The NINDS conducts and supports research on trauma-related disorders such as whiplash. Much of this research focuses on increasing scientific understanding of these disorders and finding ways to prevent and treat them.
Question: What are the treatments for Developmental Dyspraxia ?

Answer: Treatment is symptomatic and supportive and may include occupational and speech therapy, and "cueing" or other forms of communication such as using pictures and hand gestures. Many children with the disorder require special education.